Development of a Novel Endoscopic Index and Patient-reported Outcome Measure for Clinical Trials in Participants With Permanent Ileostomy
NCT06670638 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2025-11-12
Summary
To date, patients with Crohn's Disease (CD) and permanent ileostomies have been excluded from clinical trials for new treatments. To allow this patient population to be included in clinical trials, outcome and measurement tools are needed. This study aims to develop a Patient Reported Outcome (PRO) and Endoscopic Index (EI) for patients with Crohn's Disease (CD) and permanent ileostomy. The study will enroll about 50 participants and collect videos of endoscopies that are done as part of standard of care. The videos will be centrally read to identify features that represent a broad range of inflammation and will be used to develop the EI. Participants will also be asked to participate in interviews, to understand the symptoms and impacts that are most important to participants for the development of a PRO.
Conditions
- Crohns Disease
Sponsors & Collaborators
-
University of Western Ontario, Canada
collaborator OTHER -
The Leona M. and Harry B. Helmsley Charitable Trust
collaborator OTHER -
The Cleveland Clinic
collaborator OTHER -
OPEN Health (Pharmerit)
collaborator UNKNOWN -
Alimentiv Inc.
lead OTHER
Principal Investigators
-
Florian Rieder · The Cleveland Clinic
-
Vipul Jairath · Western University, Canada
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-06-19
- Primary Completion
- 2026-06-30
- Completion
- 2027-02-28
Countries
- United States
- Canada
Study Locations
More Related Trials
-
Autologous Stem Cells in the Management of Fistulating Perianal Crohn's Disease
NCT06822686 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Effect of Exclusion Diet for Crohn's Disease Plus Enteral Nutrition on Children and Adolescents With Crohn's Disease
NCT06353633 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Investigation of Sexual Function in Crohn's Disease Patients With Perianal Fistulas
NCT01635543 ·Status: WITHDRAWN
-
The Role of IL-23-Responsive Immune Cell Subsets in Post-Operative Recurrence in Patients With Crohn's Disease.
NCT06006039 ·Status: RECRUITING
-
Randomized, Double-blind, Placebo-controlled Study in Patients With Fistulizing Crohn's Disease
NCT01624376 ·Status: COMPLETED ·Phase: PHASE2
-
Corporal Composition and Gut Microbiome Modification Through Exclusion Dietary Intervention in Crohn's Disease
NCT06933264 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Pilot Study to Explore the Role of Gut Flora in Crohn's Disease
NCT04100005 ·Status: WITHDRAWN
-
An Open Label, Prospective, One Arm, Feasibility, Study for The Use of Halevy Kit for the Treatment of Perianal Fistulas in Patients With Crohn's Disease
NCT00653094 ·Status: UNKNOWN ·Phase: NA
-
Blood and Stool Molecular Biomarkers Longitudinal Detection Study in Crohn's Disease (CD) Patients
NCT03566407 ·Status: TERMINATED ·Phase: NA
-
Crohn's Disease Endoscopic REmission Definition in an Objective Way
NCT03498625 ·Status: COMPLETED ·Phase: NA
-
Whole-Food, Plant-Based Diet for Active Crohn's Disease
NCT04982666 ·Status: WITHDRAWN ·Phase: NA
-
Study to Determine Relationship Between Serum Infliximab and Efficacy in Luminal Crohn's Disease Patients
NCT00676988 ·Status: COMPLETED
-
Predictive Factors of ANTI-TNF Response in Luminal Crohn's Disease Complicated by Abscess
NCT02856763 ·Status: COMPLETED
-
Impaired Insulin-like Growth Factor-1 (IGF-1) Generation Causes Protein Catabolism and Poor Growth in Children With Crohn Disease
NCT00946361 ·Status: TERMINATED
-
Pediatric MSC-AFP Sub-study for Crohn's Fistula
NCT03449069 ·Status: COMPLETED ·Phase: PHASE1
-
Cytokines and Genes in Therapeutic Response in Crohn's Disease
NCT03266471 ·Status: COMPLETED
-
Can CT Enteroclysis Predict the Outcome of Crohn's Disease
NCT00572780 ·Status: COMPLETED
-
A Study of the Quality of Life in Adults With Crohn's Disease With Complex Perianal Fistulas
NCT04876690 ·Status: COMPLETED
-
Prediction and Close Monitoring of Postoperative Recurrence by Intestinal Ultrasound After Ileocecal Resection in Crohn's Disease Patients
NCT05713409 ·Status: UNKNOWN
-
Crohn's Extent of Resection Trial
NCT01876264 ·Status: WITHDRAWN ·Phase: NA
-
Comparing the Quality of Life of Terminal Ileitis Patients With Crohn's Disease Treated With Anti-TNF or Surgical Resection
NCT02872506 ·Status: WITHDRAWN ·Phase: NA
-
Fecal Transplant for Crohn's Disease
NCT03078803 ·Status: COMPLETED ·Phase: PHASE2
-
Mesenteric Surgical Margin for Crohn's Disease Endoscopic Recurrence
NCT06241170 ·Status: RECRUITING ·Phase: NA
-
Observational Study of Disease Severity in Participants Diagnosed With Crohn's Disease and Long Term Impact of Treatment Strategies in Participants With Moderate to Severe Crohn's Disease (Protocol P06484)
NCT01218360 ·Status: COMPLETED
-
Vedolizumab IV 300 mg in the Treatment of Fistulizing Crohn's Disease
NCT02630966 ·Status: COMPLETED ·Phase: PHASE4